Recurrent glomerular disease after kidney transplantation
Authors:
- Christopher D. BlosserCBChristopher D. Blosser
- Roy D. BloomRBRoy D. Bloom
- 1 November 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 26 (6) , 501-508
Abstract
With improving short-term kidney transplant outcomes, recurrent glomerular disease is being increasingly recognized as an important cause of chronic allograft failure. Further understanding of the risks and pathogenesis of recurrent glomerular disease enable informed transplant decisions, along with the development of preventive and treatment strategies. Multiple observational studies have highlighted differences in rates and outcomes for various recurrent glomerular diseases, although these rates have not markedly improved over the last decade. Emerging evidence supports use of rituximab to treat recurrent primary membranous nephropathy and possibly focal segmental glomerulosclerosis (FSGS), whereas eculizumab is effective in glomerular diseases associated with complement dysregulation [C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS)]. Despite the potential for recurrence in the allograft, transplant remains the optimal therapy for patients with advanced chronic kidney disease (CKD) secondary to primary glomerular disease. Biomarkers and therapeutic options necessitate accurate pretransplant diagnoses with opportunities for improved surveillance and treatment of recurrent glomerular disease posttransplant.Keywords
This publication has 96 references indexed in Scilit:
- Dense Deposit Disease and C3 GlomerulopathySeminars in Nephrology, 2013
- Resolution of Recurrent Focal Segmental Glomerulosclerosis after RetransplantationNew England Journal of Medicine, 2012
- Long-term Outcome of Renal Transplantation Patients with Henoch-Schönlein PurpuraClinical Journal of the American Society of Nephrology, 2011
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- Recurrent Glomerulonephritis Under Rapid Discontinuation of SteroidsTransplantation, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- Recurrence of Lupus Nephritis after Kidney TransplantationJournal of the American Society of Nephrology, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Probability, Predictors, and Prognosis of Posttransplantation GlomerulonephritisJournal of the American Society of Nephrology, 2009
- RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN RENAL ALLOGRAFTSTransplantation, 1981